Home Details
| Official Symbol of Gene | CTLA4 |
| Species | Homo sapiens |
| Entrez Gene ID | 1493 |
| Official Full Name | cytotoxic T-lymphocyte associated protein 4 |
| Also known as | CD; GSE; GRD4; ALPS5; CD152; CTLA-4; IDDM12; CELIAC3 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000163599 MIM:123890; AllianceGenome:HGNC:2505 |
| Map Location | N/A |
| Variation Type | Allele |
| refSNP ID | NA |
| Detected Sample | Peripheral blood/CSF |
| Sample Detail | N/A |
| Detected Method | PCR |
| Disease | MS |
| Disease subtype | NA |
| Population | NA |
| Sample Size | 74MS/93Health |
| Pubmed ID | 10567049 |
| Year | 1999 |
| Title | CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients |
| Risk Type | Phenotypic risk |
| Main Result | Positive |
| Result | This CTLA-4 polymorphism may modulate the prognosis of patients with MS and may be relevant to generation of OCB in the CSF. |
| Mechanism/Pathway | Multiple sclerosis (MS) is widely believed to have a T-cell-mediated autoimmune etiology. The CTLA-4 gene is a strong candidate for involvement in autoimmune diseases because it plays an important role in the termination of T-cell activation. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.